Micromedic sign a non-binding memorandum of understanding

BioLight (“the Company”) hereby announce that on March 25, 2019, according to the immediate report of Micromedic Technologies Ltd. (“Micromedic”), an investee company controlled by the Company, Micromedic entered into a non-binding memorandum of understanding with Nexstage Cannabis Innovation Ltd. (“Nexstage”, for information on Nexstage, see Section 6 of the …

Continue reading

Closing of the second stage of the binding agreement of investment in and acquisition in stages of IOPtima

Tel Aviv (September 27, 2018) – Further to BioLight’s announcement dated November 21, 2017, regarding signing a binding agreement for the investment in and the acquisition in stages of its subsidiary IOPtima Ltd. (“IOPtima”or the “Company”) (the “Agreement”) by the Chinese pharmaceutical company Chengdu Kanghong Pharmaceutical Group Co. (the “Acquirer”), …

Continue reading

Agreement for the Examination of Cooperation with Wize Pharma; Immaterial Relations with an independent Director

Tel Aviv (June 12, 2018) – On June 11, 2018, Diagnostear Ltd. (“Diagnostear“)[1] entered into an agreement (the “Agreement”) with Wize Pharma Ltd. (“Wize Pharma” and together with Diagnostear  the “Parties“) to examine cooperation between the Parties for the development of a companion diagnostic tool of responders and …

Continue reading